• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327

Comprehensive Overview of 1-(1-Methylcyclobutyl)cyclopropan-1-amine (CAS No. 2138358-84-4): Properties, Applications, and Research Insights

In the realm of organic chemistry and pharmaceutical research, 1-(1-Methylcyclobutyl)cyclopropan-1-amine (CAS No. 2138358-84-4) has emerged as a compound of significant interest due to its unique structural features and potential applications. This amine derivative, characterized by its cyclopropyl and methylcyclobutyl moieties, offers a versatile scaffold for drug discovery and material science. Researchers and industry professionals are increasingly exploring its synthesis, reactivity, and utility in designing novel bioactive molecules. The compound's steric hindrance and ring strain properties make it a compelling candidate for modulating molecular interactions in complex chemical systems.

The growing demand for small-molecule building blocks in medicinal chemistry has spotlighted compounds like 1-(1-Methylcyclobutyl)cyclopropan-1-amine. Its CAS No. 2138358-84-4 is frequently searched in academic and industrial databases, reflecting its relevance in high-throughput screening and fragment-based drug design. Recent trends indicate a surge in queries related to "amine-functionalized cyclopropanes" and "constrained ring systems," underscoring the compound's alignment with current research priorities. Moreover, its potential role in addressing challenges like drug resistance and selective target engagement has sparked discussions in scientific forums.

From a synthetic perspective, 1-(1-Methylcyclobutyl)cyclopropan-1-amine exemplifies the convergence of stereoselective synthesis and green chemistry principles. Innovations in catalytic cyclopropanation and amine protection strategies have streamlined its production, reducing reliance on hazardous reagents. Environmental, Social, and Governance (ESG) considerations in chemical manufacturing further drive interest in sustainable routes for such intermediates. The compound's lipophilicity and hydrogen-bonding capacity also make it a subject of computational chemistry studies, particularly in molecular docking simulations.

Beyond pharmaceuticals, 1-(1-Methylcyclobutyl)cyclopropan-1-amine finds exploratory applications in agrochemicals and functional materials. Its rigid backbone could enhance the durability of polymer coatings or serve as a ligand in catalysis. As the scientific community prioritizes structure-activity relationship (SAR) optimization, this compound's three-dimensional complexity offers a template for probing spatial effects on biological activity. Patent analyses reveal its inclusion in claims targeting neurological disorders and metabolic diseases, though detailed mechanisms remain under investigation.

Quality control and analytical characterization of CAS No. 2138358-84-4 demand advanced techniques like HPLC-MS and NMR spectroscopy. Regulatory compliance with REACH and ICH guidelines ensures its safe handling in research settings. The compound's stability under various pH conditions and thermal profiles is frequently studied, addressing concerns about degradation pathways in formulation development. Such data is critical for researchers comparing it to analogous bridged bicyclic amines or spirocyclic derivatives.

In summary, 1-(1-Methylcyclobutyl)cyclopropan-1-amine represents a nexus of innovation in synthetic chemistry and applied sciences. Its CAS No. 2138358-84-4 serves as a gateway to deeper explorations of molecular diversity and therapeutic potential. As interdisciplinary collaborations expand, this compound may unlock answers to longstanding questions in chemoinformatics and precision medicine, solidifying its place in the next generation of scientific breakthroughs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)